Genetic tests are considered to be one of the most reliable diagnostic methods commonly used in medicine.
They involve an analysis of the genetic material in the form of DNA. Genetic tests make it possible, amongst others, to diagnose serious diseases and predispositions to such diseases, verify nutritional predispositions as well as those related to physical activity. The results of genetic tests are valid throughout the patient’s life.
The iGenesis examination allows for full personalisation of your diet (the daily menu).
It consists of 5 complementary modules:
The Slim Module analyses the metabolism of carbohydrates, fats and proteins, the body’s response to caloric restrictions as well as the reaction to physical activity.
The Health Module identifies the gene variants that increase the risk of arterial hypertension, hypercholesterolaemia, atherosclerosis, hyperglycaemia, type II diabetes, abdominal obesity, metabolic syndrome as well as the accumulation of visceral fat.
The Sensor Module detects genes responsible for the predispositions to lactose and fructose intolerance and to the development of coeliac disease, as well as to hypersensitivity to certain products. It provides information about sensitivity to alcohol, caffeine, sodium and nickel, as well as about the metabolism of iron.
The Micro Module analyses the absorption and transport of vitamins A, B6, B9 (folic acid), B12, C, D, E, J (choline) and minerals such as magnesium and calcium.
The Detox Module illustrates the body’s ability to remove toxins, fight free radicals and neutralise them.
The 4K examination makes it possible to assess the risk of emergence and development of aggressive prostate cancer even 20 years in advance. 4K-Test contains a special diagnostic algorithm for prostate cancer that takes into account the levels of as many as four kallikreins in blood plasma. Many experts claim that the 4K-Test performed on the basis of a blood sample makes it possible for men to detect prostate cancer at a very early stage and represents a real breakthrough in early detection of this carcinoma.
Who should havethe molecular 4K examination?
The examination is recommended for men aged 40–80 years, who:
have been preliminarily diagnosed and are considering a primary or secondary biopsy
are in the genetically-conditioned risk group (with a family history of prostate cancer in the father, paternal uncle or grandfather)
want to know about any potential disease at an early stage when it can be successfully cured
The examination is performed from a blood test collected by a nurse. The examination result is available after approximately 4 weeks.